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These results are in contrast to those obtained by SajdelSulkowska & Marotta ( 1984) , who demonstrated that in Alzheimer's disease cortex there was an increase of 87% in the free RNase activity and a decrease in inhibitor-bound RNase activity when compared with controls. We are unable to explain these differences but are carrying out further experiments to investigate whether differences might occur at the level of white and grey matter. Preliminary results with both normal and diseased tissue have demonstrated that total RNase activity in white matter is higher (approximately two-fold) than that of grey matter. This would correlate with the observation of Naber & Dahnke (1979) Alzheimer's disease (AD), a slowly progressive neuropsychiatric illness characterized by memory deficits, is the major cause of dementia among the elderly (Katzman, 1986) . The disease is associated with a loss of central cholinergic cells (Davies & Maloney, 1976) , and in some cases a noradrenergic deficit (Bondareff et al., 1982) . Recently, Summers et al. ( 1986) reported that THA ( 1,2,3,4-tetrahydro-9-aminoacridine; Tacrine), a potent, centrally acting cholinesterase inhibitor, improved symptoms in patients with moderate to severe AD; however, liver toxicity appears to be a limiting factor. The 1-hydroxyl derivative of THA (HP 029) was synthesized in our laboratories (Shutske et al., 1988) in an attempt to reduce the toxicity of THA. By providing a hydroxyl group for glucuronide conjugation, elimination might be facilitated and toxicity limited, hopefully without sacrificing cholinesterase inhibitory activity. In this regard, HP 029 was found to be active in pharmacological tests yet far less toxic than THA in acute and subchronic animal toxicology (Shutske et id, 1988). The unique high-affinity mechanism of reversible, non-covalent inhibition by which THA inhibits cholinesterase (Steinberg el ul., 1975) further increased our interest in THA-like compounds. In this report, we present the results of biochemical studies with a series of HP 029 analogues. Acetylcholinesterase (AChE) was measured in rat striatal homogenates by a modification of the method described by Ellman et al. ( I96 1 ) using acetylthiocholine as substrate. Butyrylcholinesterase (BChE) was determined in a similar manner, except that butyrylthiocholine was used as the substrate and human serum (Precilip, Biodynamics, Houston, TX) as a source of the enzyme. Biogenic amine reuptake was measured in rat brain synaptosomes by a modification (Meyerson et ul.. 1980) of the procedure described by Snyder & Coyle (1969) .
Abbreviations used: AD, Alzheimer's disease; AChE, acetylcholinesterase; I3ChE. butyrylcholincsterase; NA, noradrenaline:
THA, 1,2,3,4-tetrahydro-9-aminoacridine.
Structure-activity relationships for the inhibition of cholinesterase and noradrenaline (NA) reuptake are shown in Table 1 with THA included for comparison. In general, compounds that are unsubstituted at the 9-amino group showed good cholinesterase inhibition. Of these, the unsubstituted parent compound (HP 029) was moderately potent (lC5,1 4.8 p~) , while the 6-chloro derivative (compound 2) exhibited the strongest inhibition (lCs,, 0.01 p~) .
In marked contrast, the 7-chloro analogue (compound 4) was a very weak AChE inhibitor. The addition of a small alkyl group at the 9-amino position gave, in the case of the methyl derivative, a compound retaining good activity (AChE ICS,, of 1.8 p~) .
When aryl substituents were attached to the 9-amino function by a -CH,-linkage (benzyl analogues), there was a marked decrease in potency (compounds 7,9, 10 and 11). If the aryl group was linked to the 9-amino function by an alkyl chain longer than -CH,-(compound 8), good AChE inhibition was observed (1Cs,=3.4 p~) .
The primary amines (THA, HP 029, compounds 2,3, and 4) showed essentially no inhibition of NA uptake. Substitution of the 9-amino group with small alkyl chains had no effect, whereas attachment of arylalkyl groups led to respectable NA uptake inhibition (lC5(l < 1.8 p~) .
The phenethyl analogue (compound 8) and the 6-chloro substituted benzyl derivative (compound 12) had moderate anticholinesterase activity coupled with good NA uptake inhibition.
The present work extends previous studies with HP 029. As an AChE inhibitor, HP 029 is somewhat less active in vitro than THA and yet is as active in reversing memory deficits in cholinergically impaired animals (Shutske er al., 1988) . Thus, compounds with weak-to-moderate anticholinesterase properties, as well as the most potent AChE inhibitors of Table 1 , were considered for further investigation. THA, for example, has recently been reported to have ion-channel effects (Drukarch et al., 1987 , Schauf Sr Sattin, 1987 ) that may increase the release of endogenous neurotransmitters. Such effects could contribute to the usefulness of THA-like compounds in AD. The effects of halogen substitution on the acridine nucleus are also worthy of additional study. Whereas THA and HP 029 are more potent as inhibitors of BChE than AChE (Table 1 ; Heilbronn, 1961) , halogen substitution at the 6-position of the aromatic ring, in addition to cnhancing AChE inhibitory activity, reversed the selectivity of inhibition (i.e. AChE inhibition > BChE). 627th MEETING, NOTTINGHAM Y-amino-1,2,3,4-tetruhydroacridin-l01s on striatal AChE, serum BChE and NA synaptosomal uptake IC,,, represents the concentration of compound required to produce a 50% inhibition of enzyme activity or NA uptake. Values are calculated from percentage inibition, using at least six different concentrations of each compound, by computer-derived logprobit analyses; n.d., not determined. release effects of THA (Drukarch et ul., 1988) . Indeed, many of the benzyl derivatives were more potent than the tricyclic antidepressant, desipramine, (Meyerson et ul., 1980) A most interesting observation was that scvcral !&amino bcnzyl substituted analogues were also potent inhibitors of biogcnic amine uptake. T h e inhibition of N A uptake by compounds 7 ( H P 128), 9, 10 and 12 occurred at substantially lower concentrations than the reported ion channcl (Drukarch et ul., 1987; Schauf & Sattin, 1987) Little work has been done on D N A repair in Alzheimer's disease ( A D ) cells, but several recent studies have indicated that these cells, like Down's syndrome lymphocytes, may be more sensitive than normals to DNA-damaging agents. We recently examined (Smith et ul., 1987) D N A repair after p irradiation in lymphocytes from AD and from normal individuals by measuring unscheduled DNA synthesis (UDS). Vie have now examined DNA replication and rate of rejoining of single-strand breaks in these cells after irradiation.
For replication studies, lymphocytes were Firradiated with 1.25 or 3.25 Gy and after 4 h, a known number of cells was stimulated with phytohaemagglutinin ( P H A ) and then maintained in culture medium; 66 h later they were incubated with ['Hlthymidine for 1 h. Triplicate measurements were made on most samples. In some cases, the number of viable cells was counted just before addition of [3H]thymidine so that the incorporation per cell numbers present (as opposed to the incorporation per initial number of unstimulated cells) could be calculated.
In unirradiated lymphocytes, ['Hlthymidine incorporation was about 40% lower into A D cells than into age-matched normals; also, there was a slight, but not statistically significant, decrease in uptake with age into normals. However, Abbreviations used: AD, Alzheimer's disease; PHA, phytohaemagglutinin; UDS, unscheduled DNA synthesis. incorporation into irradiated, stimulated cells, expressed as a percentage of the uptake into unirradiated cells, was similar for A D patients, normal age-matched individuals and young and old normals.
These results indicate that after irradiation, D N A synthesis is quantitatively similar in those A D cells and normal cells, from donors of various ages, that survive for at least several days after treatment. A s to unirradiated cells, it appears that fewer A D than normal lymphocytes are stimulated by the mitogen, i.e. therc may be an abnormality of T-cell function in A D .
To investigate initial damage and initial rate of repair after irradiation, we examined the size of the D N A in PHA-stimulated lymphocytes at various times after irradiation. The D N A was radiolabelled by incubation of cells with ['Hlthymidine, usually 50 h after stimulation (we checked that the level of 3H incorporation was not such as to cause strand-breaks). Cells were then irradiated with 150 Gy, lysed on alkaline sucrose gradients and centrifuged at 18°C for 2 h at 29 000 rev./min (Spinco SW41Ti rotor, Beckman ultracentrifuge). After fractionation of gradients by upward displacement, D N A peaks were located by scintillation counting of each fraction. Values of average molecular mass (single-stranded) from old and young normal individuals and from AD patients ( u ) were similar in non-irradiated lymphocytes; ( 6 ) decreased to a similar extent in cells lysed immediately after irradiation; ( c ) returned almost to the original pre-irradiation level in cells allowed a 50 min repair period after irradiation. Since 50 min might have been too long to reveal any differences in rate of repair, a 15 min period was tried also; however, no difference was found between values for young and old normals and A D patients. Thus, these
